☆ 4.7 Article

Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton's Tyrosine Kinase for the Treatment of Lymphoma

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Related references

Note: Only part of the references are listed.

Review Chemistry, Medicinal

Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib

Fansheng Ran et al.

Summary: Bruton's tyrosine kinase (BTK) plays a crucial role in the treatment of hematologic malignancies, but current therapies have limitations. Therefore, researchers are exploring new treatment strategies, such as next-generation BTK inhibitors, BTK-PROTACs, and combination therapies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Recent development of BTK-based dual inhibitors in the treatment of cancers

Fansheng Ran et al.

Summary: This review highlights the potential of BTK-based dual inhibitors in the treatment of various cancers and discusses the current status and future options in this field. It emphasizes the feasibility of these inhibitors for refractory tumors, including those with drug resistance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Designing Soluble PROTACs: Strategies and Preliminary Guidelines

Diego Garcia Jimenez et al.

Summary: Solubility optimization is crucial for obtaining oral PROTACs. Lipophilicity plays a major role in governing solubility, but the contribution of polarity cannot be neglected. By using infographic tools and machine learning, a privileged region for soluble PROTACs was identified, providing promising guidelines for optimizing PROTAC solubility.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo

Mingming Wei et al.

Summary: This study developed a novel PROTAC molecule based on Ribociclib derivative, which can effectively degrade CDK 2/4/6, induce apoptosis and cell cycle arrest in malignant melanoma cells. Additionally, an orally bioavailable prodrug was developed for the first time, providing a convenient solution for animal testing of PROTAC molecules derived from CRBN ligands.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Instruments & Instrumentation

Exploration of Principal Component Analysis: Deriving Principal Component Analysis Visually Using Spectra

J. Renwick Beattie et al.

Summary: Spectroscopy rapidly captures a large amount of data, which is processed using principal component analysis to simplify complex spectral datasets into comprehensible information. Despite its wide use, the linear algebra behind principal component analysis is often not well understood by applied scientists and spectroscopists. The process traces the journey of spectra and relies solely on the information within the spectra to provide meaningful interpretation and analysis.

APPLIED SPECTROSCOPY (2021)

Add to Collection

Article Chemistry, Medicinal

Discovery of novel BTK PROTACs for B-Cell lymphomas

Yunpeng Zhao et al.

Summary: BTK is a key drug target for B-cell malignancies, and the covalent BTK inhibitors face drug resistance issues. PROTAC technology can increase sensitivity to drug-resistant targets, and ARQ531 as a non-covalent BTK inhibitor may serve as an ideal warhead for PROTACs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Computer Science, Artificial Intelligence

Effective dimensionality reduction by using soft computing method in data mining techniques

A. Radhika et al.

Summary: The research discusses methods for handling daily data generation and transmission, proposing dimensionality reduction techniques to simplify data processing and using decision tree algorithms to analyze optimal crop yields. By employing principal component analysis in the agriculture domain, dimension reduction algorithms are utilized for enhanced performance.

SOFT COMPUTING (2021)

Add to Collection

Article Chemistry, Medicinal

Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity

Victoria G. Klein et al.

Summary: The study explores the potential of enhancing PROTAC permeability and bioactivity by replacing amides with esters, leading to the design of novel VHL-based BET degraders. Ester PROTACs exhibited improved cell permeability and more potent protein degradation effects.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Development of BTK Inhibitors: A Five-Year Update

Bruno Tasso et al.

Summary: BTK has been a significant target for therapeutic agents in cancer and autoimmune disorders, with both irreversible and reversible inhibitors being developed and investigated. Research on BTK function and inhibitors is of interest for pharmaceutical companies and academia.

MOLECULES (2021)

Add to Collection

Article Neurosciences

Estimating brain age from structural MRI and MEG data: Insights from dimensionality reduction techniques

Alba Xifra-Porxas et al.

Summary: This study aimed to investigate whether combining MRI with MEG information improves brain age prediction. The results showed that a stacking model combining both feature sets improved age prediction performance and CCA with Gaussian process regression models yielded the best prediction performance.

NEUROIMAGE (2021)

Add to Collection

Article

Surface Electromyography Based Core Muscle Fatigue Analysis During Repetitive Plank Using Multivariate Dimensionality Reduction Methods in Boys Aged 12-14

Abir Samanta et al.

Teoria ta Metodika Fizicnogo Vihovanna (2021)

Add to Collection

Article Chemistry, Medicinal

Prediction of Chameleonic Efficiency

Laurent David et al.

Summary: This study introduces the application of chameleonic properties in drug molecules, establishing models for predicting drug polarity and hydrogen bond donor characteristics through experimental measurement models and molecular dynamics simulations. These methods can be useful for triaging designed molecules and prioritizing those with the best chance of achieving acceptable permeability and solubility.

CHEMMEDCHEM (2021)

Add to Collection

Article Chemistry, Medicinal

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Weiguo Xiang et al.

Summary: This study identifies a promising AR degrader for the treatment of advanced prostate cancer, which demonstrates potent inhibition in cell lines with AR gene amplification or mutations and shows good oral bioavailability in mice.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Chemistry, Medicinal

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Xin Han et al.

Summary: This study outlines strategies for discovering highly potent PROTAC degraders of androgen receptor (AR) with excellent oral pharmacokinetics, successfully identifying compound ARD-2128 as the most effective in inhibiting tumor growth in mice with good oral bioavailability.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Fundamental aspects of DMPK optimization of targeted protein degraders

Carina Cantrill et al.

DRUG DISCOVERY TODAY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs

Ronen Gabizon et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Add to Collection

Review Dermatology

Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors

Vincent Sibaud et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective

Andy Pike et al.

DRUG DISCOVERY TODAY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Functional characterization of a PROTAC directed against BRAF mutant V600E

Ganna Posternak et al.

NATURE CHEMICAL BIOLOGY (2020)

Add to Collection

Article Mathematical & Computational Biology

High-dimensional integrative copula discriminant analysis for multiomics data

Yong He et al.

STATISTICS IN MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Wen-Hao Guo et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Nutrition & Dietetics

Dietary patterns derived from principal component analysis (PCA) and risk of colorectal cancer: a systematic review and meta-analysis

Vanessa Garcia-Larsen et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)

Add to Collection

Review Chemistry, Medicinal

Bruton's tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018)

Yifan Feng et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2019)

Add to Collection

Letter Oncology

Degradation of Bruton's tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas

Yonghui Sun et al.

LEUKEMIA (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

First targeted protein degrader hits the clinic

Asher Mullard

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Review Chemistry, Medicinal

Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges

Scott D. Edmondson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Arvinas’s PROTACs pass first safety and PK analysis

Asher Mullard

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding

Christopher P. Tinworth et al.

ACS CHEMICAL BIOLOGY (2019)

Add to Collection

Meeting Abstract Oncology

ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer

J. J. Flanagan et al.

CANCER RESEARCH (2019)

Add to Collection

Article Chemistry, Medicinal

Protein Degradation via CRL4CRBN Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1

Joshua D. Hansen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Chemistry, Medicinal

Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression

Bing Zhou et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Letter Cell Biology

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

Yonghui Sun et al.

CELL RESEARCH (2018)

Add to Collection

Article Immunology

Principle component analysis (PCA) for investigation of relationship between population dynamics of microbial pathogenesis, chemical and sensory characteristics in beef slices containing Tarragon essential oil

Behrooz Alizadeh Behbahani et al.

MICROBIAL PATHOGENESIS (2017)

Add to Collection

Article Computer Science, Artificial Intelligence

Dimensionality reduction in data mining: A Copula approach

Rima Houari et al.

EXPERT SYSTEMS WITH APPLICATIONS (2016)

Add to Collection

Review Biotechnology & Applied Microbiology

Chemical predictive modelling to improve compound quality

John G. Cumming et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Add to Collection

Article Chemistry, Medicinal

Bruton's Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies

Yan Lou et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Add to Collection

Article Statistics & Probability

Discriminant analysis

Geoffrey J. McLachlan

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS (2012)

Add to Collection

Article Statistics & Probability

Principal component analysis

Herve Abdi et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS (2010)

Add to Collection

Review Biochemistry & Molecular Biology

Structure - ADME relationship: still a long way to go?

Tingjun Hou et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)

Add to Collection

Article Biotechnology & Applied Microbiology

ADMET - turning chemicals into drugs

J Hodgson

NATURE BIOTECHNOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.